Anticoagulation in COVID-19: reaction to the ACTION trial

Authors

Jeffrey S. Berger, NYU Grossman School of Medicine
Jean Marie Connors, Brigham and Women's Hospital

Document Type

Journal Article

Publication Date

6-12-2021

Journal

The Lancet

Volume

397

Issue

10291

DOI

10.1016/S0140-6736(21)01291-5

APA Citation

Berger, J., & Connors, J. (2021). Anticoagulation in COVID-19: reaction to the ACTION trial. The Lancet, 397 (10291). http://dx.doi.org/10.1016/S0140-6736(21)01291-5